RALOXIFENE HYDROCHLORIDE
solid
science Other reagents with same CAS 82640-04-8
blur_circular Chemical Specifications
description Product Description
Used primarily in the prevention and treatment of osteoporosis in postmenopausal women. It helps maintain bone density and reduces the risk of fractures. Additionally, it is prescribed to lower the risk of invasive breast cancer in postmenopausal women who are at high risk or have osteoporosis. It works by mimicking the effects of estrogen on bone tissue while blocking estrogen’s effects in breast and uterine tissue. Often taken as a once-daily oral tablet, it is a selective estrogen receptor modulator (SERM) that balances bone health and cancer risk.
format_list_bulleted Product Specification
| Test Parameter | Specification |
|---|---|
| Assay | 98.5-101.5% |
| Appearance | Yellowish Powder |
| Loss on Drying | <=0.5 |
| Residue on Ignition | <=0.1 |
| Heavy Metals | <=10 ppm |
shopping_cart Available Sizes & Pricing
Cart
No products